← Eichor
Study identifier: NCT06416761 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genetics in the Progression of Nephropathies

Condition: AKI · CKD · Ckd-Mbd  ·  Sponsor: Ospedale San Raffaele

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to: * AKI * CKD * Hypertension * ADPKD * CKD-MBD * Patients with decompensated heart failure undergoing either medical or surgery therapy * Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation * glomerular diseases

This description comes directly from the study's public registry record.

Talk to the study team

Chiara Livia Lanzani, prof  ·  +393408163279  ·  lanzani.chiara@hsr.it

Laura Zagato, biologist  ·  +390226435745  ·  zagato.laura@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS Ospedale San RaffaeleMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06416761